Pharma Stocks Get Hit As Biden Weighs In… Plus Tesla’s Delivery Beat 7/2/24
CNBC's "Fast Money"
00:00
Intro
Discussion on the repercussions in pharma stocks after President Biden and Senator Sanders criticized the high prices of GLP1 weight loss drugs, highlighting the need for Medicare price negotiations and the potential for heightened scrutiny on pharmaceutical companies before the presidential election.
Play episode from 00:00
Transcript
